Advanced Research Projects Agency for Health (ARPA-H) Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) Program
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Advanced Research Projects Agency for Health (ARPA-H) has issued a Presolicitation (DRAFT) for its Small Business Innovation Research (SBIR) / Small Business Technology Transfer (STTR) Program. This initiative seeks proposals from small businesses for innovative research and development (R&D) that addresses ARPA-H mission needs and accelerates health outcomes. The program aims to support high-impact solutions to challenging health problems, focusing on novel approaches rather than incremental advances.
Purpose & Scope
ARPA-H is soliciting proposals from Small Business Concerns (SBCs) with R&D expertise to conduct innovative research. The program's objectives include stimulating technological innovation, strengthening small business participation in federal R&D, fostering participation by disadvantaged and women-owned businesses, and increasing private sector commercialization of innovations. The solicitation anticipates including seven specific research topics:
- ARPA-H 01: Development of an annual test to inform women about their future fertility.
- ARPA-H 02: Versatile Bioadhesives (surgical glues with antimicrobial properties).
- ARPA-H 03: Universal Platform for Living Adaptive Toxin-removal (UNI-PLAT).
- ARPA-H 04: Curative, Non-Invasive, Long-Lasting Therapy for Endometriosis.
- ARPA-H 05: ARPA-H Lineage Topic (advancing ARPA-H funded technologies).
- ARPA-H 06: Rapid Comprehensive Diagnostic Test for Multi-System Autoimmune Disease.
- ARPA-H 07: Virtual Human Brain for the Development of Neurosurgical Robotics.
Contract Details & Eligibility
- Contract Type: Firm-Fixed-Price (FFP) awards.
- Phases: Projects are structured into Phase I (Feasibility) and Phase II (Full R&D Effort). Direct-to-Phase II and Fast Track awards are also accepted.
- Set-Aside: This is a Total Small Business Set-Aside (FAR 19.5).
- Eligibility: Proposers must be Small Business Concerns (SBCs) with no more than 500 employees (including affiliates), primarily operating in the U.S., and majority-owned/controlled by U.S. citizens/permanent residents or specific venture capital entities. Registration in SBA Company Registry and SAM.gov is required.
Submission & Evaluation
Submissions will follow a two-stage process: Stage 1 involves a Solution Summary (using the provided template), and Stage 2 requires a Technical Presentation for invited proposers. Evaluation criteria include Technical Merit, Technical Novelty, Team & Relevant Experience, Path to Impact and Health Outcomes, and Cost. Required attachments for the technical presentation include a Task Description Document (TDD), GANTT chart, and cost proposal, for which templates are provided. Submissions must be made via the ARPA-H Solutions site.
Key Dates & Information
- Feedback/Questions Deadline: May 6, 2026, 5:00 PM ET (submit via solutions.arpa-h.gov/ask-a-question).
- Proposers' Day: A virtual Proposers' Day will be held on June 11, 2026, from 10:00 AM to 1:00 PM ET. Registration opens April 22, 2026, and closes 48 hours before the event. Attendance is optional but highly encouraged.
- Solicitation Release: Anticipated TBD (Solicitation 75N99226R00002).
- Proposal Closing Date: Anticipated TBD.
- Note: This is a DRAFT presolicitation and all information is subject to change. Proposers should monitor SAM.gov for updates.